Human genome comparison of paretic and nonparetic vastus lateralis muscle in patients with hemiparetic stroke

Abstract

Hemiparetic stroke leads to major skeletal muscle abnormalities, as illustrated by paretic leg atrophy, weakness, and spasticity. Furthermore, the hemiparetic limb muscle shifts to a fast-twitch muscle fiber phenotype with anaerobic metabolism. This study investigated whether skeletal muscle genes were altered in chronic hemiparetic stroke. The nonparetic leg muscle served as an internal control. We used Affymetrix microarray analysis to survey gene expression differences between paretic and nonparetic vastus lateralis muscle punch biopsies from 10 subjects with chronic hemiparetic stroke. Stroke latency was greater than 6 months. We found that 116 genes were significantly altered between the paretic and non paretic vastus lateralis muscles. These gene differences were consistent with reported differences after stroke in areas such as injury and inflammation markers, the myosin heavy chain profile, and high prevalence of impaired glucose tolerance and type 2 diabetes. Furthermore, while many other families of genes were altered, the gene families with the most genes altered included inflammation, cell cycle regulation, signal transduction, metabolism, and muscle contractile protein genes. This study is an early step toward identification of specific gene regulatory pathways that might lead to these differences, propagate disability, and increase vascular disease risk.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1

Proposed influences of stroke on skeletal muscle and possible gene clusters induced by these muscle changes.

Figure 2

Genes reported as significantly changed, shown grouped by cluster. Genes in nonparetic (NP) bars had lower expression in paretic (P) than NP vastus lateralis (VL) muscle, while genes in P bars had higher expression in P than NP VL muscle.